Hub : Traits :

Medication: Amlodipine

41 significantly associated models · 24 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 10435170 12600396 2 2 1.3e-08 8.5e-21 2.8e-13 39 CLCN6 RP4-635E18.7
2 1 27013133 28406173 1 1 9.0e-08 1.1e-05 5.4e-01 98 CD164L2
3 1 112312154 113907148 3 1 4.7e-10 9.4e-15 4.2e-12 20 WNT2B
4 2 26291565 27689899 1 2 1.3e-07 6.2e-12 5.5e-07 47 SLC35F6
5 3 26720690 28211713 1 1 1.8e-07 5.3e-07 2.3e-03 63 SLC4A7
6 8 90252801 91709053 1 1 4.0e-07 1.5e-07 8.0e-02 89 NBN
7 11 1213806 2640824 2 1 4.4e-12 4.1e-12 6.1e-02 93 TNNT3
8 11 46033104 47419663 1 1 9.2e-08 5.9e-07 1.7e-01 93 ZNF408
9 11 99859184 101559718 2 1 1.4e-09 4.8e-09 2.2e-01 96 TMEM133
10 12 121146219 122706844 2 1 1.6e-07 8.8e-08 1.0e+00 100 RNF34
11 15 80377452 81936479 1 1 2.3e-08 9.1e-09 1.0e+00 100 KIAA1199
12 15 90730363 92135418 1 1 1.8e-08 6.1e-08 6.0e-02 88 FES
13 17 25990033 27387415 1 1 2.6e-07 5.9e-06 1.1e-04 27 TMEM199
14 17 55903829 57920532 5 1 7.1e-09 2.9e-08 2.9e-02 84 SKA2

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 1.70 2 0 0.0 0.00 1.0e+00 FES KIAA1199
Irritable Bowel Disease (IBD) 1.42 1 0 0.0 0.00 1.0e+00 FES
Major Depression (MDD) 1.68 1 0 0.0 0.00 1.0e+00 FES
Reaction Time 1.78 1 0 0.0 0.00 1.0e+00 SKA2
Breast Cancer 7.46 3 2 6.1 0.00 1.0e+00 FES SLC4A7 TNNT3
Ovarian Cancer 2.06 1 0 0.0 0.00 1.0e+00 FES
Crohns Disease (2012) 1.70 2 0 0.0 0.00 1.0e+00 FES KIAA1199
Fasting Glucose 2.28 2 0 0.0 0.00 1.0e+00 RNF34 ZNF408
HDL Cholesterol 2.55 1 1 3.0 0.00 1.0e+00 ZNF408
LDL Cholesterol 1.66 1 0 0.0 0.00 1.0e+00 TMEM199
Schizophrenia 2.03 2 1 3.0 0.00 1.0e+00 FES SLC35F6
Type 2 Diabetes (T2D) 2.37 1 0 0.0 0.00 1.0e+00 SKA2
Blood Eosinophil Count 0.62 2 0 0.0 0.00 1.0e+00 CD164L2 KIAA1199
Blood Platelet Count 0.91 4 1 3.0 0.22 7.8e-01 CLCN6 SLC4A7 TMEM199 WNT2B
Blood Red Count 0.89 4 1 3.0 0.61 3.9e-01 CLCN6 FES NBN SLC35F6
Blood White Count 1.24 5 2 6.1 0.43 4.0e-01 FES KIAA1199 SLC35F6 SLC4A7 TMEM133
Heel T-Score 2.03 5 4 12.1 0.81 9.5e-02 RP4-635E18.7 SLC4A7 TMEM133 TMEM199 ZNF408
BMI 1.87 5 2 6.1 -0.71 1.1e-01 CLCN6 KIAA1199 RNF34 SLC35F6 ZNF408
Height 0.86 10 3 9.1 0.60 6.6e-02 FES RNF34 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199 TNNT3 WNT2B ZNF408
Waist Hip Ratio (WHR) 0.95 2 0 0.0 0.00 1.0e+00 TMEM133 TNNT3
Systolic Blood Pressure 21.02 15 12 36.4 -0.86 4.1e-05 CD164L2 CLCN6 FES KIAA1199 NBN RNF34 RP4-635E18.7 SKA2 SLC35F6 SLC4A7 TMEM133 TMEM199 TNNT3 WNT2B ZNF408
Smoking Status 1.69 3 0 0.0 0.00 1.0e+00 FES KIAA1199 NBN
Allergy or Eczema 2.05 3 0 0.0 0.00 1.0e+00 CLCN6 FES RNF34
Cardiovascular Disease 17.11 13 13 39.4 -0.95 1.3e-07 CD164L2 CLCN6 FES KIAA1199 RNF34 RP4-635E18.7 SKA2 SLC35F6 SLC4A7 TMEM133 TNNT3 WNT2B ZNF408
Respiratory disease 1.28 1 0 0.0 0.00 1.0e+00 FES
Type 2 Diabetes (T2D) 1.15 1 0 0.0 0.00 1.0e+00 SKA2
Lung FEV1/FVC ratio 0.95 1 1 3.0 0.00 1.0e+00 TMEM133
Lung FVC 0.72 2 0 0.0 0.00 1.0e+00 SLC35F6 ZNF408
Neuroticism 1.39 2 0 0.0 0.00 1.0e+00 SKA2 ZNF408
Chronotype (morning person) 1.40 1 0 0.0 0.00 1.0e+00 SKA2
Hair Pigment 0.25 4 2 6.1 0.97 3.4e-02 FES RP4-635E18.7 TMEM133 ZNF408
Tanning 0.28 2 0 0.0 0.00 1.0e+00 CLCN6 TMEM133
Hand grip strength (left) 0.92 1 0 0.0 0.00 1.0e+00 WNT2B
Number of treatments/medications taken 4.71 3 2 6.1 0.00 1.0e+00 FES KIAA1199 TMEM133
Sensitivity / hurt feelings 1.96 2 0 0.0 0.00 1.0e+00 FES SKA2
Systolic blood pressure, automated reading 14.79 11 6 18.2 0.88 3.9e-04 CLCN6 FES KIAA1199 RP4-635E18.7 SKA2 SLC4A7 TMEM133 TMEM199 TNNT3 WNT2B ZNF408
Angina 3.87 2 1 3.0 0.00 1.0e+00 FES TMEM133
Impedance of leg (right) 2.04 6 1 3.0 -0.36 4.3e-01 CD164L2 FES KIAA1199 SLC35F6 SLC4A7 TMEM133
Leg fat-free mass (left) 1.97 5 2 6.1 0.46 3.6e-01 KIAA1199 RP4-635E18.7 SLC35F6 TMEM133 TMEM199
Trunk fat percentage 2.04 5 1 3.0 0.47 4.3e-01 KIAA1199 RNF34 SLC35F6 TNNT3 ZNF408
Hand grip strength (right) 1.22 1 0 0.0 0.00 1.0e+00 WNT2B
Fed-up feelings 1.52 1 0 0.0 0.00 1.0e+00 ZNF408
Taking other prescription medications 1.44 1 0 0.0 0.00 1.0e+00 KIAA1199
Age when periods started (menarche) 1.12 1 0 0.0 0.00 1.0e+00 TNNT3
Heel bone mineral density (BMD) T-score, automated (left) 1.84 3 0 0.0 0.00 1.0e+00 TMEM133 TMEM199 ZNF408
High blood pressure 19.43 14 12 36.4 0.95 6.2e-08 CD164L2 CLCN6 FES KIAA1199 NBN RNF34 RP4-635E18.7 SKA2 SLC35F6 SLC4A7 TMEM133 TNNT3 WNT2B ZNF408
Hayfever, allergic rhinitis or eczema 1.69 1 0 0.0 0.00 1.0e+00 RNF34
Medication: Atenolol 6.95 6 1 3.0 0.95 4.2e-03 CLCN6 FES KIAA1199 TMEM133 TNNT3 WNT2B
Sitting height 1.14 6 0 0.0 0.65 1.6e-01 CD164L2 FES KIAA1199 SLC35F6 SLC4A7 ZNF408
High blood pressure (mother) 8.93 6 1 3.0 0.92 8.5e-03 CLCN6 FES RNF34 SLC4A7 TMEM133 TNNT3
Body mass index (BMI) 1.69 5 1 3.0 0.98 2.9e-03 KIAA1199 RNF34 SKA2 SLC35F6 ZNF408
Impedance of leg (left) 2.07 7 1 3.0 -0.43 2.9e-01 CD164L2 FES KIAA1199 SLC35F6 SLC4A7 TMEM133 WNT2B
Leg predicted mass (left) 1.97 5 2 6.1 0.46 3.5e-01 KIAA1199 RP4-635E18.7 SLC35F6 TMEM133 TMEM199
Trunk fat mass 1.98 5 1 3.0 0.69 2.0e-01 KIAA1199 RNF34 RP4-635E18.7 SLC35F6 ZNF408
Waist circumference 1.96 3 2 6.1 0.00 1.0e+00 KIAA1199 SKA2 SLC35F6
Number of incorrect matches in round 1.76 1 0 0.0 0.00 1.0e+00 ZNF408
Past tobacco smoking 1.35 1 0 0.0 0.00 1.0e+00 KIAA1199
Alcohol usually taken with meals 1.60 1 0 0.0 0.00 1.0e+00 FES
Forced vital capacity (FVC) 1.35 3 0 0.0 0.00 1.0e+00 TMEM133 WNT2B ZNF408
Heel bone mineral density (BMD) T-score, automated (right) 1.97 3 0 0.0 0.00 1.0e+00 TMEM133 TMEM199 ZNF408
Heart attack 3.05 2 0 0.0 0.00 1.0e+00 CD164L2 FES
Allergy 1.56 2 0 0.0 0.00 1.0e+00 FES RNF34
Medication: Ramipril 5.51 3 1 3.0 0.00 1.0e+00 FES TMEM133 TNNT3
Medication: Simvastatin 4.53 2 0 0.0 0.00 1.0e+00 FES TMEM133
Illnesses of siblings 4.70 3 1 3.0 0.00 1.0e+00 FES SLC4A7 TMEM133
Neuroticism score 1.26 1 0 0.0 0.00 1.0e+00 ZNF408
Weight 1.91 4 2 6.1 0.72 1.7e-01 KIAA1199 RP4-635E18.7 SKA2 SLC35F6
Impedance of arm (right) 1.22 3 0 0.0 0.00 1.0e+00 KIAA1199 SLC4A7 TNNT3
Arm fat percentage (right) 1.90 5 1 3.0 0.71 1.8e-01 CLCN6 KIAA1199 RNF34 SLC35F6 ZNF408
Trunk fat-free mass 1.62 5 2 6.1 0.52 2.9e-01 KIAA1199 SLC35F6 SLC4A7 TMEM133 TMEM199
Hip circumference 2.06 5 2 6.1 0.60 2.9e-01 CLCN6 KIAA1199 SKA2 SLC35F6 ZNF408
Father's age at death 1.99 1 0 0.0 0.00 1.0e+00 FES
Forced expiratory volume in 1-second (FEV1) 1.34 3 0 0.0 0.00 1.0e+00 TMEM133 WNT2B ZNF408
Medication: Cholesterol lowering 4.35 3 2 6.1 0.00 1.0e+00 CLCN6 FES TMEM133
Illnesses of mother 6.07 3 1 3.0 0.00 1.0e+00 FES TMEM133 TNNT3
Forced expiratory volume in 1-second (FEV1), Best measure 1.29 2 1 3.0 0.00 1.0e+00 TMEM133 ZNF408
Pulse wave Arterial Stiffness index 2.17 1 0 0.0 0.00 1.0e+00 CLCN6
Impedance of arm (left) 1.35 3 1 3.0 0.00 1.0e+00 KIAA1199 SLC4A7 TNNT3
Arm fat mass (right) 1.87 4 1 3.0 0.98 2.4e-02 KIAA1199 RNF34 SLC35F6 ZNF408
Trunk predicted mass 1.60 5 2 6.1 0.53 2.8e-01 KIAA1199 SLC35F6 SLC4A7 TMEM133 TMEM199
Standing height 0.86 4 1 3.0 -0.59 4.1e-01 RP4-635E18.7 SLC35F6 WNT2B ZNF408
Breastfed as a baby 1.11 1 0 0.0 0.00 1.0e+00 FES
Birth weight of first child 3.94 2 2 6.1 0.00 1.0e+00 CLCN6 FES
Blood clot in the leg (DVT) 1.84 1 0 0.0 0.00 1.0e+00 ZNF408
Medication: Paracetamol 1.17 1 0 0.0 0.00 1.0e+00 KIAA1199
Headache pain in last month 2.17 1 0 0.0 0.00 1.0e+00 SKA2
Medication for cholesterol, blood pressure or diabetes 10.70 7 3 9.1 -0.93 2.0e-03 CLCN6 FES KIAA1199 SLC4A7 TMEM133 WNT2B ZNF408
Birth weight 2.25 1 1 3.0 0.00 1.0e+00 FES
High blood pressure (siblings) 7.23 6 1 3.0 0.98 3.5e-04 CLCN6 FES KIAA1199 SLC4A7 TMEM133 TNNT3
Forced vital capacity (FVC), Best measure 1.29 2 1 3.0 0.00 1.0e+00 WNT2B ZNF408
Body fat percentage 2.06 5 0 0.0 0.69 2.0e-01 CLCN6 KIAA1199 RNF34 SLC35F6 ZNF408
Leg fat percentage (right) 1.88 5 0 0.0 0.63 2.6e-01 CLCN6 RNF34 SKA2 SLC35F6 ZNF408
Arm fat-free mass (right) 1.59 6 1 3.0 0.46 3.0e-01 KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199
Worry too long after embarrassment 0.92 1 0 0.0 0.00 1.0e+00 WNT2B
Pulse wave peak to peak time 2.25 1 0 0.0 0.00 1.0e+00 CLCN6
Medication for pain relief, constipation, heartburn 1.97 1 0 0.0 0.00 1.0e+00 KIAA1199
Medication: Blood pressure 15.48 11 7 21.2 0.96 3.3e-06 CD164L2 CLCN6 FES KIAA1199 RNF34 RP4-635E18.7 SLC4A7 TMEM133 TNNT3 WNT2B ZNF408
Angina (self-reported) 3.70 2 1 3.0 0.00 1.0e+00 FES TMEM133
Migraine (self-reported) 1.01 1 0 0.0 0.00 1.0e+00 ZNF408
Mean time to correctly identify matches 1.87 2 0 0.0 0.00 1.0e+00 SKA2 SLC4A7
Heart disease (mother) 3.19 2 0 0.0 0.00 1.0e+00 FES SLC4A7
Whole body fat mass 1.90 4 1 3.0 0.98 2.3e-02 KIAA1199 RNF34 SLC35F6 ZNF408
Leg fat mass (right) 1.87 4 1 3.0 0.98 1.7e-02 KIAA1199 RNF34 SLC35F6 ZNF408
Arm predicted mass (right) 1.63 6 1 3.0 0.47 2.9e-01 KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199
Pulse rate, automated reading 1.06 2 0 0.0 0.00 1.0e+00 SLC4A7 WNT2B
Comparative height size at age 10 1.14 3 2 6.1 0.00 1.0e+00 KIAA1199 RP4-635E18.7 ZNF408
Suffer from 'nerves' 1.40 1 0 0.0 0.00 1.0e+00 SKA2
Overall health rating 1.36 1 0 0.0 0.00 1.0e+00 ZNF408
Medication: Aspirin 4.42 2 1 3.0 0.00 1.0e+00 FES RNF34
Knee pain experienced in last month 1.66 1 0 0.0 0.00 1.0e+00 KIAA1199
Hypertension (Self-reported) 19.43 15 12 36.4 0.94 7.8e-08 CD164L2 CLCN6 FES KIAA1199 NBN RNF34 RP4-635E18.7 SKA2 SLC35F6 SLC4A7 TMEM133 TMEM199 TNNT3 WNT2B ZNF408
Gastro-oesophageal reflux (gord) / gastric reflux (Self-reported) 1.61 1 0 0.0 0.00 1.0e+00 RNF34
Illnesses of father: Heart disease 3.40 1 1 3.0 0.00 1.0e+00 FES
Smoking status: Previous 1.29 1 0 0.0 0.00 1.0e+00 KIAA1199
Whole body fat-free mass 1.76 6 2 6.1 0.48 2.7e-01 KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199
Leg fat-free mass (right) 2.06 7 2 6.1 0.45 2.7e-01 FES KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199
Arm fat percentage (left) 1.98 4 1 3.0 1.00 2.0e-03 KIAA1199 RNF34 SLC35F6 ZNF408
Mood swings 1.54 1 0 0.0 0.00 1.0e+00 NBN
Loneliness, isolation 1.52 1 0 0.0 0.00 1.0e+00 NBN
Friendships satisfaction 1.78 1 0 0.0 0.00 1.0e+00 SLC35F6
Mouth/teeth dental problems: Mouth ulcers 1.79 1 0 0.0 0.00 1.0e+00 NBN
Medication for cholesterol 8.38 9 2 6.1 -0.99 6.2e-09 CD164L2 CLCN6 KIAA1199 RNF34 RP4-635E18.7 SLC35F6 TMEM133 TNNT3 WNT2B
Breast cancer (self-reported) 2.69 1 1 3.0 0.00 1.0e+00 SLC4A7
Medication: Aspirin 4.99 2 1 3.0 0.00 1.0e+00 FES RNF34
Illnesses of father: None of the above (group 1) 4.54 1 1 3.0 0.00 1.0e+00 FES
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.15 2 0 0.0 0.00 1.0e+00 TMEM133 ZNF408
Whole body water mass 1.78 6 2 6.1 0.48 2.8e-01 KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199
Leg predicted mass (right) 2.05 7 2 6.1 0.45 2.7e-01 FES KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199
Arm fat mass (left) 1.83 4 1 3.0 0.98 2.5e-02 KIAA1199 RNF34 SLC35F6 ZNF408
Number of self-reported non-cancer illnesses 3.90 4 0 0.0 1.00 9.7e-04 CLCN6 KIAA1199 RNF34 TMEM133
Miserableness 1.69 1 0 0.0 0.00 1.0e+00 ZNF408
Mother's age at death 2.47 1 0 0.0 0.00 1.0e+00 CLCN6
Tinnitus: Yes, now most or all of the time 1.50 1 0 0.0 0.00 1.0e+00 WNT2B
Medication: Blood pressure 15.18 12 7 21.2 0.98 5.8e-09 CD164L2 CLCN6 FES KIAA1199 RNF34 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TNNT3 WNT2B ZNF408
High cholesterol (Self-reported) 4.02 3 1 3.0 0.00 1.0e+00 CD164L2 CLCN6 TMEM133
Medication: Bendroflumethiazide 11.30 11 4 12.1 0.99 1.8e-08 CD164L2 CLCN6 FES KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TNNT3 WNT2B ZNF408
Medication: Lisinopril 4.18 1 0 0.0 0.00 1.0e+00 TMEM133
Illnesses of father: High blood pressure 6.60 4 1 3.0 0.01 9.9e-01 CLCN6 FES SLC4A7 TMEM133
Ever smoked 1.51 1 0 0.0 0.00 1.0e+00 RNF34
Basal metabolic rate 1.78 6 1 3.0 0.50 2.5e-01 KIAA1199 RP4-635E18.7 SLC35F6 SLC4A7 TMEM133 TMEM199
Leg fat percentage (left) 1.88 6 0 0.0 0.72 1.0e-01 CLCN6 KIAA1199 RNF34 SKA2 SLC35F6 ZNF408
Arm fat-free mass (left) 1.61 4 1 3.0 0.71 1.8e-01 KIAA1199 SLC35F6 SLC4A7 TMEM199
Risk taking 2.14 1 0 0.0 0.00 1.0e+00 SLC35F6
Diastolic blood pressure, automated reading 11.15 9 6 18.2 0.87 2.3e-03 CLCN6 FES KIAA1199 RP4-635E18.7 SKA2 TMEM133 TNNT3 WNT2B ZNF408
Myopia 1.30 1 0 0.0 0.00 1.0e+00 WNT2B
Vascular/heart problems diagnosed by doctor 18.80 13 11 33.3 -0.95 3.1e-07 CD164L2 CLCN6 FES KIAA1199 RNF34 RP4-635E18.7 SKA2 SLC35F6 SLC4A7 TMEM133 TNNT3 WNT2B ZNF408
Cholesterol lowering medication 3.62 2 0 0.0 0.00 1.0e+00 RNF34 SKA2
Pain experienced in last month 2.05 1 0 0.0 0.00 1.0e+00 KIAA1199
Heart attack/myocardial infarction (self-reported) 2.99 2 0 0.0 0.00 1.0e+00 CD164L2 FES
Deep venous thrombosis (DVT) (self-reported) 1.85 1 0 0.0 0.00 1.0e+00 ZNF408
Heart disease (siblings) 1.82 1 0 0.0 0.00 1.0e+00 FES
Impedance of whole body 1.58 5 1 3.0 -0.61 2.8e-01 KIAA1199 SLC35F6 SLC4A7 TMEM133 TNNT3
Leg fat mass (left) 1.80 4 1 3.0 0.98 1.9e-02 KIAA1199 RNF34 SLC35F6 ZNF408
Arm predicted mass (left) 1.66 4 1 3.0 0.72 1.7e-01 KIAA1199 SLC35F6 SLC4A7 TMEM199

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 2 0.0573 1.48
GTEx Adipose Visceral Omentum 0 0.0000 1.47
GTEx Adrenal Gland 1 0.0686 1.46
GTEx Artery Aorta 3 0.1008 1.45
GTEx Artery Coronary 0 0.0000 1.52
GTEx Artery Tibial 4 0.1064 1.49
GTEx Brain Caudate basal ganglia 0 0.0000 1.43
GTEx Brain Cerebellar Hemisphere 0 0.0000 1.34
GTEx Brain Cerebellum 0 0.0000 1.38
GTEx Brain Cortex 0 0.0000 1.40
GTEx Brain Frontal Cortex BA9 0 0.0000 1.43
GTEx Brain Hippocampus 0 0.0000 1.46
GTEx Brain Hypothalamus 0 0.0000 1.38
GTEx Brain Nucleus accumbens basal ganglia 0 0.0000 1.35
GTEx Brain Putamen basal ganglia 0 0.0000 1.30
GTEx Breast Mammary Tissue 0 0.0000 1.47
GTEx Breast Mammary Tissue (Male) 1 0.0838 1.44
GTEx Breast Mammary Tissue (Female) 1 0.0608 1.50
GTEx Cells EBV-transformed lymphocytes 0 0.0000 1.43
GTEx Cells Transformed fibroblasts 3 0.0714 1.41
GTEx Colon Sigmoid 0 0.0000 1.49
GTEx Colon Transverse 0 0.0000 1.48
GTEx Esophagus Gastroesophageal Junction 0 0.0000 1.53
GTEx Esophagus Mucosa 0 0.0000 1.44
GTEx Esophagus Muscularis 0 0.0000 1.48
GTEx Heart Atrial Appendage 0 0.0000 1.40
GTEx Heart Left Ventricle 0 0.0000 1.39
GTEx Liver 0 0.0000 1.31
GTEx Lung 2 0.0696 1.47
GTEx Muscle Skeletal 2 0.0692 1.44
GTEx Nerve Tibial 3 0.0694 1.39
GTEx Ovary 0 0.0000 1.50
GTEx Pancreas 0 0.0000 1.52
GTEx Pituitary 0 0.0000 1.37
GTEx Prostate 0 0.0000 1.49
GTEx Skin Not Sun Exposed Suprapubic 1 0.0407 1.49
GTEx Skin Sun Exposed Lower leg 0 0.0000 1.44
GTEx Small Intestine Terminal Ileum 0 0.0000 1.39
GTEx Spleen 0 0.0000 1.48
GTEx Stomach 1 0.0688 1.53
GTEx Testis 1 0.0317 1.42
GTEx Thyroid 0 0.0000 1.43
GTEx Uterus 0 0.0000 1.39
GTEx Vagina 0 0.0000 1.48
GTEx Whole Blood 1 0.0502 1.43
METSIM Adipose 3 0.0651 1.36
NTR Blood 0 0.0000 1.40
ROSMAP Brain Pre-frontal Cortex 3 0.0683 1.48
YFS Blood 1 0.0217 1.30
CommonMind Brain Pre-frontal Cortex 2 0.0372 1.38
TCGA Breast Tumor 0 0.0000 1.48
TCGA Breast Normal 3 0.0713 1.34
TCGA Ovarian Tumor 0 0.0000 1.30
TCGA Prostate Tumor 3 0.0867 1.42